These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7613073)

  • 1. Phosphorothioate oligonucleotides cause degradation of secretory but not intracellular serglycin proteoglycan core protein in a sequence-independent manner in human megakaryocytic tumor cells.
    Schick BP; Eras JL; Mintz PS
    Antisense Res Dev; 1995; 5(1):59-65. PubMed ID: 7613073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serglycin and betaglycan proteoglycans are expressed in the megakaryocytic cell line CHRF 288-11 and normal human megakaryocytes.
    Schick BP; Jacoby JA
    J Cell Physiol; 1995 Oct; 165(1):96-106. PubMed ID: 7559813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agents.
    Wu AG; Joshi SS; Chan WC; Iversen PL; Jackson JD; Kessinger A; Pirruccello SJ; Sanger WG; Sharp JG; Verbik DJ
    Leuk Lymphoma; 1995 Dec; 20(1-2):67-76. PubMed ID: 8750625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative effect of c-myc antisense phosphorothioate oligodeoxynucleotides in malignant glioma cells.
    Broaddus WC; Chen ZJ; Prabhu SS; Loudon WG; Gillies GT; Phillips LL; Fillmore H
    Neurosurgery; 1997 Oct; 41(4):908-15. PubMed ID: 9316053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonantisense sequence-selective effect of a phosphorothioate oligodeoxynucleotide directed against the epidermal growth factor receptor in A431 cells.
    Coulson JM; Poyner DR; Chantry A; Irwin WJ; Akhtar S
    Mol Pharmacol; 1996 Aug; 50(2):314-25. PubMed ID: 8700139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serglycin proteoglycan is sorted into zymogen granules of rat pancreatic acinar cells.
    Biederbick A; Licht A; Kleene R
    Eur J Cell Biol; 2003 Jan; 82(1):19-29. PubMed ID: 12602945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice.
    Leonetti C; D'Agnano I; Lozupone F; Valentini A; Geiser T; Zon G; Calabretta B; Citro G C; Zupi G
    J Natl Cancer Inst; 1996 Apr; 88(7):419-29. PubMed ID: 8618233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of mRNA for serglycin core protein and other platelet alpha granule proteins is increased in human erythroleukemia cells by phorbol myristate acetate.
    Schick BP; Thornton RD
    Leukemia; 1993 Dec; 7(12):1955-9. PubMed ID: 7504770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter regulatory elements and DNase I-hypersensitive sites involved in serglycin proteoglycan gene expression in human erythroleukemia, CHRF 288-11, and HL-60 cells.
    Schick BP; Petrushina I; Brodbeck KC; Castronuevo P
    J Biol Chem; 2001 Jul; 276(27):24726-35. PubMed ID: 11333275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNase I hypersensitivity patterns of the serglycin proteoglycan gene in resting and phorbol 12-myristate 13-acetate-stimulated human erythroleukemia (HEL), CHRF 288-11, and HL-60 cells compared with neutrophils and human umbilical vein endothelial cells.
    Castronuevo P; Thornton MA; McCarthy LE; Klimas J; Schick BP
    J Biol Chem; 2003 Dec; 278(49):48704-12. PubMed ID: 14506241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of expression of megakaryocyte and platelet proteoglycans.
    Schick BP
    Stem Cells; 1996; 14 Suppl 1():220-31. PubMed ID: 11012225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
    Lin JQ; Xu ZS; Zhang HY; Yang ZW; Xu YH
    Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):241-6. PubMed ID: 8571707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by phosphorothioate antisense oligodeoxynucleotides is the consequence of antisense-specific and antisense-non-specific effects.
    Hertl M; Neckers LM; Katz SI
    J Invest Dermatol; 1995 May; 104(5):813-8. PubMed ID: 7738361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, secretion, and subcellular localization of serglycin proteoglycan in human endothelial cells.
    Schick BP; Gradowski JF; San Antonio JD
    Blood; 2001 Jan; 97(2):449-58. PubMed ID: 11154222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serglycin proteoglycan expression and synthesis in embryonic stem cells.
    Schick BP; Ho HC; Brodbeck KC; Wrigley CW; Klimas J
    Biochim Biophys Acta; 2003 Feb; 1593(2-3):259-67. PubMed ID: 12581870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.
    Perez JR; Li Y; Stein CA; Majumder S; van Oorschot A; Narayanan R
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5957-61. PubMed ID: 8016096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human serglycin gene. Nucleotide sequence and methylation pattern in human promyelocytic leukemia HL-60 cells and T-lymphoblast Molt-4 cells.
    Humphries DE; Nicodemus CF; Schiller V; Stevens RL
    J Biol Chem; 1992 Jul; 267(19):13558-63. PubMed ID: 1377686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the serglycin gene in human leukemic cell lines.
    Maillet P; Alliel PM; Mitjavila MT; Périn JP; Jollès P; Bonnet F
    Leukemia; 1992 Nov; 6(11):1143-7. PubMed ID: 1434796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular delivery is a major obstacle for oligodeoxynucleotide inhibition of telomerase activity.
    Duncan VE; Ajmani PS; Hughes JA
    Anticancer Res; 1998; 18(6A):4105-8. PubMed ID: 9891453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of functional efficacy of phosphorothioate-modified oligonucleotides in a human CD8+ T-cell ex vivo expansion model.
    Al-Shanti NA; Steward CG; Garland RJ
    Scand J Immunol; 2003 Oct; 58(4):462-70. PubMed ID: 14507311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.